BedaquilineCAS# 843663-66-1 |
- Leupeptin, Microbial
Catalog No.:BCC1217
CAS No.:103476-89-7
- AEBSF.HCl
Catalog No.:BCC1219
CAS No.:30827-99-7
- PMSF
Catalog No.:BCC1229
CAS No.:329-98-6
- Nafamostat Mesylate(FUT-175)
Catalog No.:BCC1228
CAS No.:82956-11-4
- Aprotinin
Catalog No.:BCC1220
CAS No.:9087-70-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 843663-66-1 | SDF | Download SDF |
| PubChem ID | 5388906 | Appearance | Powder |
| Formula | C31H29BrN2O | M.Wt | 525.5 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | TMC207; R207910 | ||
| Solubility | DMSO : 20 mg/mL (36.00 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) | ||
| Chemical Name | (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol | ||
| SMILES | CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O | ||
| Standard InChIKey | QUIJNHUBAXPXFS-XLJNKUFUSA-N | ||
| Standard InChI | InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Bedaquiline Dilution Calculator
Bedaquiline Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9029 mL | 9.5147 mL | 19.0295 mL | 38.059 mL | 47.5737 mL |
| 5 mM | 0.3806 mL | 1.9029 mL | 3.8059 mL | 7.6118 mL | 9.5147 mL |
| 10 mM | 0.1903 mL | 0.9515 mL | 1.9029 mL | 3.8059 mL | 4.7574 mL |
| 50 mM | 0.0381 mL | 0.1903 mL | 0.3806 mL | 0.7612 mL | 0.9515 mL |
| 100 mM | 0.019 mL | 0.0951 mL | 0.1903 mL | 0.3806 mL | 0.4757 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Bedaquiline, a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.
In Vitro:Bedaquiline inhibits the growth of TDR M. tuberculosis strains, with MIC values ranging from 0.125 to 0.5 mg/L[1]. Among slowly growing mycobacteria (SGM), bedaquiline exhibits the highest activity against Mycobacterium avium with MIC50 and MIC90 values of 0.03 and 16 mg/L, respectively. Among rapidly growing mycobacteria (RGM), Mycobacterium abscessus subsp. abscessus (M. abscessus) and Mycobacterium abscessus subsp. massiliense (M. massiliense) seem more susceptible to bedaquiline than Mycobacterium fortuitum, with MIC50 and MIC90 values of 0.13 and >16 mg/L, respectively, for both species. Bedaquiline also shows moderate in vitro activity against NTM species[2]. Bedaquiline has an excellent in vitro activity against Mycobacterium tuberculosis, including multidrug resistant M tuberculosis[3].
References:
[1]. Jang JC, et al. Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis. J Microbiol. 2017 Apr 20.
[2]. Pang Y, et al. In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China. Antimicrob Agents Chemother. 2017 Apr 24;61(5).
[3]. Chahine EB, et al. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother. 2014 Jan;48(1):107-15.
- Rabdosin B
Catalog No.:BCN3236
CAS No.:84304-92-7
- 4,4'-Cyclohexylidenebisphenol
Catalog No.:BCC8663
CAS No.:843-55-0
- Pterosin D 3-O-glucoside
Catalog No.:BCN4567
CAS No.:84299-80-9
- Aliarin
Catalog No.:BCN3919
CAS No.:84294-77-9
- 5-O-Methylvisammioside
Catalog No.:BCN4954
CAS No.:84272-85-5
- Raclopride
Catalog No.:BCC7184
CAS No.:84225-95-6
- AKT Kinase Inhibitor
Catalog No.:BCC1335
CAS No.:842148-40-7
- Canagliflozin
Catalog No.:BCC3696
CAS No.:842133-18-0
- Cyclosomatostatin
Catalog No.:BCC7693
CAS No.:84211-54-1
- Sudan I
Catalog No.:BCN8378
CAS No.:842-07-9
- 7 8-Dihydroxy-4-Phenylcoumarin
Catalog No.:BCC8289
CAS No.:842-01-3
- Ac-Glu(OtBu)-OH
Catalog No.:BCC2921
CAS No.:84192-88-1
- Mifepristone
Catalog No.:BCC4486
CAS No.:84371-65-3
- Adoxosidic acid
Catalog No.:BCN7593
CAS No.:84375-46-2
- Neuromedin S (rat)
Catalog No.:BCC6055
CAS No.:843782-19-4
- Bretazenil
Catalog No.:BCC7711
CAS No.:84379-13-5
- alpha-Arbutin
Catalog No.:BCN8336
CAS No.:84380-01-8
- 23-Hydroxybetulin
Catalog No.:BCN6463
CAS No.:84414-40-4
- Fmoc-NH2
Catalog No.:BCC2803
CAS No.:84418-43-9
- AT7519
Catalog No.:BCC2541
CAS No.:844442-38-2
- A-769662
Catalog No.:BCC2080
CAS No.:844499-71-4
- β-CCB
Catalog No.:BCC6635
CAS No.:84454-35-3
- threo-Guaiacylglycerol-beta-O-4'-dehydrodisinapyl ether
Catalog No.:BCN6928
CAS No.:844637-85-0
- C-1
Catalog No.:BCC6687
CAS No.:84468-24-6
Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.[Pubmed:28320727]
Antimicrob Agents Chemother. 2017 May 24;61(6). pii: AAC.00239-17.
Clofazimine has been repurposed for the treatment of tuberculosis, especially for multidrug-resistant tuberculosis (MDR-TB). To test the susceptibility to clofazimine of Mycobacterium tuberculosis clinical isolates, MICs of clofazimine were determined using the microplate alamarBlue assay (MABA) method for 80 drug-resistant isolates and 10 drug-susceptible isolates for comparison. For five clofazimine-resistant strains isolated from previously treated pre-extensively drug-resistant TB (pre-XDR-TB) and XDR-TB patients without prior exposure to clofazimine or Bedaquiline, clofazimine MICs were >/=1.2 mug/ml. Four isolates with cross-resistance to Bedaquiline had Rv0678 mutations. The other isolate with no resistance to Bedaquiline had an Rv1979c mutation. This study adds to a recent study showing that 6.3% of MDR-TB patients without prior clofazimine or Bedaquiline exposure harbored isolates with Rv0678 mutations, which raises concern that preexisting resistance to these drugs may be associated with prior TB treatment. Furthermore, we propose a tentative breakpoint of 1.2 mug/ml for clofazimine resistance using the MABA method. More-widespread surveillance and individualized testing for clofazimine and Bedaquiline resistance, together with assessment of their clinical usage, especially among previously treated and MDR-TB patients, are warranted.
